Insurance coverage strategy : Employers and benefits managers should evaluate GLP-1 coverage within their pharmacy benefit plans to ensure cost-effective, high-quality options for members
Tirzepatide is both a glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist
While originally developed and primarily used for the treatment of type 2 diabetes, Ozempic has also been approved by the U.S
A body of evidence has indicated that IR is closely related to the occurrence and development of hypertension (110)
No supplement or medication should be assumed safe to combine with retatrutide without a thorough clinical assessment
"By bringing the API manufacturing domestic, we can control far more of the process end to end, giving us advantages in quality and purity and reliability and ultimately, in brand trust that I think will be incredibly difficult for others to match and I think increasingly important as these treatments and therapeutics become more mass market," Dudum said during the call